eli lilly & co s tirzepatide FDA approves tirzepatide, Lilly's new type 2 diabetes drug, and the company shares an estimated price Phase III Trial Shows Lilly's

Key Takeaways Tirzepatide hair loss is usually temporary and linked to significant weight loss, metabolic stress, or nutritional deficiencies, not direct follicle damage

Some providers recommend methenamine hippurate as a non-antibiotic prophylactic option for patients who want to avoid long-term antibiotic use

(Ideally, you want a pharmacy where the pharmacists are board-certified sterile compounding pharmacists, or BCSCPs.) Does a third-party lab test your compounded medications

WeightWatchers flips the model, starting with behavior change and layering in GLP-1 meds after

Electrolytes support nerve signaling and muscle function, both of which decline when fluids are low

Matthew FoxMorgan Stanley Wealth ManagementIndianapolisIndiana - Indianapolis$1M$595M$750K-10M$750K-25MDavid TiddJ.P